Ertapenem, sold under the brand name Invanz, is a carbapenem antibiotic medication used for the treatment of infections of the abdomen, the lungs, the...
20 KB (1,717 words) - 09:59, 6 August 2024
combinations: Carbapenems: (meropenem, imipenem/cilastatin, doripenem - NOT ertapenem) Meropenem/vaborbactam Imipenem/cilastatin/relebactam Others: Fluoroquinolones:...
30 KB (747 words) - 08:06, 6 January 2024
pneumoniae and other carbapenem-resistant Enterobacteriaceae). The carbapenem ertapenem is one of several first-line agents recommended by the Infectious Disease...
30 KB (3,489 words) - 16:49, 6 July 2024
Ceftobiprole (Broadest spectrum of β-lactam antibiotics) Biapenem Doripenem Ertapenem Faropenem Imipenem Meropenem Panipenem Razupenem Tebipenem Thienamycin...
4 KB (175 words) - 02:53, 1 June 2024
carbapenems cover Gram-positives, Gram-negatives, and anaerobes except for ertapenem. The only fluoroquinolone that can be used is moxifloxacin because this...
22 KB (2,109 words) - 16:50, 8 August 2024
once-daily ertapenem for the treatment of cIAI. A total of 541 patients were included and eravacycline demonstrated noninferiority to ertapenem. An additional...
16 KB (1,483 words) - 06:47, 29 June 2024
intravenous ertapenem therapy showed clinical improvement with 80.3% of subjects reporting medium to high satisfaction and 90.8% would recommend ertapenem to other...
58 KB (5,763 words) - 10:38, 30 August 2024
penicillins, cephalosporins, cephamycins, monobactams and carbapenems (ertapenem), although carbapenems are relatively resistant to beta-lactamase. Beta-lactamase...
53 KB (6,263 words) - 14:38, 30 May 2024
further progression of their disease in over 6 months of follow-up. Invanz (Ertapenem) is an injectable antibiotic, rights to which Merck has owned since 1999...
96 KB (9,423 words) - 09:49, 4 September 2024
susceptibility patterns must be taken into account when deciding on treatment. Ertapenem is a potential effective alternative treatment for ceftriaxone-resistant...
56 KB (5,661 words) - 07:45, 16 August 2024